{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:55:02Z","timestamp":1768870502792,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,15]]},"DOI":"10.7759\/cureus.33806","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T04:57:30Z","timestamp":1673845050000},"source":"Crossref","is-referenced-by-count":3,"title":["Gastrointestinal Stromal Tumor Recurrence Presenting as a Small Bowel Obstruction: A Case Report"],"prefix":"10.7759","author":[{"given":"Dana A","family":"Neama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah J","family":"Al Araibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amer E","family":"Alderazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayed Ali I","family":"Almahari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulrahman M","family":"Alawadhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.32074\/1591-951X-309","article-title":"Mesenchymal tumours of the gastrointestinal tract","volume":"113","author":"Sbaraglia M","year":"2021","unstructured":"Sbaraglia M, Businello G, Bellan E, Fassan M, Dei Tos AP. Mesenchymal tumours of the gastrointestinal tract. Pathologica. 2021, 113:230-51. 10.32074\/1591-951X-309","journal-title":"Pathologica"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e31822d63a7","article-title":"Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables","volume":"35","author":"Rossi S","year":"2011","unstructured":"Rossi S, Miceli R, Messerini L, et al.. Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables. Am J Surg Pathol. 2011, 35:1646-56. 10.1097\/PAS.0b013e31822d63a7","journal-title":"Am J Surg Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2016.08.019","article-title":"Pancreatic gastrointestinal stromal tumor: a case report","volume":"29","author":"Elgeidie A","year":"2016","unstructured":"Elgeidie A, El-Magd EA, El-Maaty SR, El-Hawary AK. Pancreatic gastrointestinal stromal tumor: a case report. Int J Surg Case Rep. 2016, 29:67-70. 10.1016\/j.ijscr.2016.08.019","journal-title":"Int J Surg Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-200407000-00007","article-title":"KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications","volume":"28","author":"Medeiros F","year":"2004","unstructured":"Medeiros F, Corless CL, Duensing A, et al.. KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol. 2004, 28:889-94. 10.1097\/00000478-200407000-00007","journal-title":"Am J Surg Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v24.i26.2806","article-title":"Current clinical management of gastrointestinal stromal tumor","volume":"24","author":"Akahoshi K","year":"2018","unstructured":"Akahoshi K, Oya M, Koga T, Shiratsuchi Y. Current clinical management of gastrointestinal stromal tumor. World J Gastroenterol. 2018, 24:2806-17. 10.3748\/wjg.v24.i26.2806","journal-title":"World J Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-01026-6","article-title":"The management of metastatic GIST: current standard and investigational therapeutics","volume":"14","author":"Kelly CM","year":"2021","unstructured":"Kelly CM, Gutierrez Sainz L, Chi P. The management of metastatic GIST: current standard and investigational therapeutics. J Hematol Oncol. 2021, 14:2. 10.1186\/s13045-020-01026-6","journal-title":"J Hematol Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.5858\/2006-130-1466-GSTROM","article-title":"Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis","volume":"130","author":"Miettinen M","year":"2006","unstructured":"Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006, 130:1466-78. 10.5858\/2006-130-1466-GSTROM","journal-title":"Arch Pathol Lab Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S5634","article-title":"Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment","volume":"6","author":"Deshaies I","year":"2010","unstructured":"Deshaies I, Cherenfant J, Gusani NJ, et al.. Gastrointestinal stromal tumor (GIST) recurrence following surgery: review of the clinical utility of imatinib treatment. Ther Clin Risk Manag. 2010, 6:453-8. 10.2147\/TCRM.S5634","journal-title":"Ther Clin Risk Manag"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20862","article-title":"Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden","volume":"103","author":"Nilsson B","year":"2005","unstructured":"Nilsson B, B\u00fcmming P, Meis-Kindblom JM, et al.. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden. Cancer. 2005, 103:821-9. 10.1002\/cncr.20862","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1009199108","article-title":"Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations","volume":"108","author":"Janeway KA","year":"2011","unstructured":"Janeway KA, Kim SY, Lodish M, et al.. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations. Proc Natl Acad Sci U S A. 2011, 108:314-8. 10.1073\/pnas.1009199108","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","article-title":"Gastrointestinal stromal tumors\u2014diagnosis and management: a brief review","volume":"8","author":"Gerrish ST","year":"2008","unstructured":"Gerrish ST, Smith JW. Gastrointestinal stromal tumors\u2014diagnosis and management: a brief review. Ochsner J. 2008, 8:197-204.","journal-title":"Ochsner J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2018.08.20","article-title":"Gastrointestinal stromal tumors: a comprehensive review","volume":"10","author":"Parab TM","year":"2019","unstructured":"Parab TM, DeRogatis MJ, Boaz AM, et al.. Gastrointestinal stromal tumors: a comprehensive review. J Gastrointest Oncol. 2019, 10:144-54. 10.21037\/jgo.2018.08.20","journal-title":"J Gastrointest Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e32830138f9","article-title":"Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis","volume":"19","author":"Mearadji A","year":"2008","unstructured":"Mearadji A, den Bakker MA, van Geel AN, et al.. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis. Anticancer Drugs. 2008, 19:607-12. 10.1097\/CAD.0b013e32830138f9","journal-title":"Anticancer Drugs"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota S","year":"1998","unstructured":"Hirota S, Isozaki K, Moriyama Y, et al.. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998, 279:577-80. 10.1126\/science.279.5350.577","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1126\/science.1079666","article-title":"PDGFRA activating mutations in gastrointestinal stromal tumors","volume":"299","author":"Heinrich MC","year":"2003","unstructured":"Heinrich MC, Corless CL, Duensing A, et al.. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003, 299:708-10. 10.1126\/science.1079666","journal-title":"Science"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/132450-gastrointestinal-stromal-tumor-recurrence-presenting-as-a-small-bowel-obstruction-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:42Z","timestamp":1707508122000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/132450-gastrointestinal-stromal-tumor-recurrence-presenting-as-a-small-bowel-obstruction-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,15]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.33806","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,15]]}}}